The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes proposed by the Central Government, anchored on section 159 of the Patents Act, 1970. The government seeks to amend the …
If tariffs were the big-ticket issue of trade disputes in an earlier decade, intellectual property rights (IPRs) are making for all the drama, standoffs and skulduggery in international negotiations today. Why are IPRs so crucial to the new economic order? To understand this one needs to come to terms with …
WHAT RICH COUNTRIES SAY AND WHAT THEY ACTUALLY DO is worlds apart. At the just concluded round of discussions on ACTA, the controversial Anti- Counterfeiting Trade Agreement, in Lucerne in Switzerland, the countries trying to steamroller a plurilateral pact to tighten enforcement of global intellectual property (IP) rules made some …
Feeding the world is going to require the scientific and financial muscle of agricultural biotechnology companies. Natasha Gilbert asks whether they're up to the task.
SEVERAL industrialized countries are negotiating a treaty that could deny developing countries access to low-cost medicines, making them dependent on expensive patented drugs. The pact is very likely to go further than the World Trade Organization’s (WTO’s) trademark- related arrangements by branding any item suspected of violating patents as counterfeit. …
An empirical study of the impact of patenting and licensing on regional manufacturing of human papilloma virus vaccines to help improve vaccine affordability and access.
The introduction of genetic engineering (GE) in plant breeding has been accompanied by the expansion of patent monopolies. Companies have seized on the opportunity to extend the corporate control of agriculture through the patenting of seeds and plants. Increasing corporate control has meant the seed industry has been largely integrated …
The demands of global capital, mediated through the market, are increasingly driving the trajectory of advances in science. Today this acts as the principal barrier to the advance of science as a knowledge system that is designed to serve the needs of the people. The needs of a neo-liberal economic …
Monsanto's way of calculating royalty on its Bt cotton seeds raises serious questions about how tenable it is Latha Jishnu / New Delhi June 24, 2010, 0:11 IST For years now, at least since India passed amendments to the Patent Act to allow product patents in 2005, patents on drugs …
An anti-cancer drug extracted from cow urine and developed by an affiliate of the RSS has got a third US patent for its anti-genotoxicity properties. The same extract, developed by RSS backed Go Vigyan Anusandhan Kendra, had earlier got the US patent as a bio- enhancer with antibiotics and anti-cancer …
GLENMARK Pharmaceuticals has scored in its patent tussle with Sanofi Aventis and Abbott after a New Jersey district court upheld the challenge by the Indian company for a hyper-tension drug. Glenmark was the first to file the challenge for the drug combination that contains a slow release and an immediate …
a symposium organized in Delhi recently by the George Washington University in the US is the latest in the series of events to promote patent interests of pharma companies. One of the main sponsors of the event, US pharma company Gilead Sciences, made a presentation at the symposium on its …
In 2007, a paper in the journal Cancer Cell announced that the compound dichloroacetate (DCA) had been found to shrink tumours in rats (S. Bonnet et al. Cancer Cell 11, 37
Investors Put Off By 2016 Launch Date Given To Glenmark, Stock Sheds 1.7% GLENMARK Pharmaceuticals and US drugmaker Merck & Co have settled out of court their patent dispute over cholesterol control drug ezetimibe but investors were unimpressed with the terms of the deal, sending the company
Our Bureau NEW DELHI SWISS drugmaker Roche lost the patent in India for its anti-viral drug, Valcyte, widely used by AIDS patients, after the patent office concluded it did not contain the necessary innovation to qualify for marketing exclusivity, said lawyers involved in the case. The ruling would help local …
